References
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988. https://doi.org/10.1161/01.STR.22.8.983
- Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart 1999;82:547-554. https://doi.org/10.1136/hrt.82.5.547
- January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1-e76. https://doi.org/10.1016/j.jacc.2014.03.022
- Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383:955-962. https://doi.org/10.1016/S0140-6736(13)62343-0
- Corrado G, Tadeo G, Beretta S, et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 1999;115:140-143. https://doi.org/10.1378/chest.115.1.140
Cited by
- Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis : A case report and literature review vol.95, pp.49, 2016, https://doi.org/10.1097/md.0000000000005577
- Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis vol.46, pp.3, 2016, https://doi.org/10.1007/s11239-018-1693-3